SPX-301

N/A

Report date: 2023/03/12 17:03:56

Base Information

Drug NameSPX-301

Drug Alias NameSPX-301

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionProgrammed death-ligand 1 blockersAnti-CLDN18

TargetsProgrammed death-ligand 1Claudin-18 splice variant 2

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesSparx Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesSparx Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A